Mauri Giovanni, Cova Luca, De Beni Stefano, Ierace Tiziana, Tondolo Tania, Cerri Anna, Goldberg S Nahum, Solbiati Luigi
Unit of Interventional Oncologic Radiology, Department of Diagnostic Imaging, Azienda Ospedaliera Ospedale di Circolo di Busto Arsizio, Busto Arsizio, Varese, Italy,
Cardiovasc Intervent Radiol. 2015 Feb;38(1):143-51. doi: 10.1007/s00270-014-0897-y. Epub 2014 May 8.
This study was designed to assess feasibility of US-CT/MRI fusion-guided ablation in liver tumors undetectable with US.
From 2002 to 2012, 295 tumors (162 HCCs and 133 metastases; mean diameter 1.3 ± 0.6 cm, range 0.5-2.5 cm) detectable on contrast-enhanced CT/MRI, but completely undetectable with unenhanced US and either totally undetectable or incompletely conspicuous with contrast-enhanced US (CEUS), were treated in 215 sessions using either internally cooled radiofrequency or microwave with standard ablation protocols, guided by an image fusion system (Virtual Navigation System, Esaote S.p.A., Genova, Italy) that combines US with CT/ MRI images. Correct targeting and successful ablation of tumor were verified after 24 hours with CT or MRI.
A total of 282 of 295 (95.6 %) tumors were correctly targeted with successful ablation achieved in 266 of 295 (90.2 %). Sixteen of 295 (5.4 %) tumors were correctly targeted, but unsuccessfully ablated, and 13 of 295 (4.4 %) tumors were unsuccessfully ablated due to inaccurate targeting. There were no perioperative deaths. Major complications were observed in 2 of the 215 treatments sessions (0.9 %).
Real-time virtual navigation system with US-CT/MRI fusion imaging is precise for targeting and achieving successful ablation of target tumors undetectable with US alone. Therefore, a larger population could benefit from ultrasound guided ablation procedures.
本研究旨在评估超声-CT/MRI融合引导下对超声不可见的肝脏肿瘤进行消融的可行性。
2002年至2012年期间,对295个肿瘤(162个肝细胞癌和133个转移瘤;平均直径1.3±0.6cm,范围0.5 - 2.5cm)进行了治疗,这些肿瘤在增强CT/MRI上可检测到,但在未增强超声下完全不可见,在增强超声(CEUS)下要么完全不可见要么显示不完全清晰。采用标准消融方案,使用内部冷却的射频或微波,在一个将超声与CT/MRI图像相结合的图像融合系统(虚拟导航系统,意大利热那亚的百胜医疗集团)引导下,进行了215次治疗。24小时后用CT或MRI验证肿瘤的正确靶向和成功消融。
295个肿瘤中共有282个(95.6%)被正确靶向,295个中有266个(90.2%)成功消融。295个肿瘤中有16个(5.4%)被正确靶向但消融未成功,295个中有13个(4.4%)因靶向不准确而消融未成功。无围手术期死亡。215次治疗中有2次(0.9%)观察到主要并发症。
具有超声-CT/MRI融合成像的实时虚拟导航系统在靶向和成功消融单独超声不可见的目标肿瘤方面是精确的。因此,更多患者可从超声引导的消融手术中获益。